Free Trial

Scopus BioPharma (SCPS) Competitors

Scopus BioPharma logo
$0.0003 0.00 (-70.00%)
As of 10/14/2025 02:17 PM Eastern

SCPS vs. SMFL, VRPX, VAXX, TRVN, ARDS, NAVB, GNCAQ, GNCA, STAB, and EVLO

Should you be buying Scopus BioPharma stock or one of its competitors? The main competitors of Scopus BioPharma include Smart for Life (SMFL), Virpax Pharmaceuticals (VRPX), Vaxxinity (VAXX), Trevena (TRVN), Aridis Pharmaceuticals (ARDS), Navidea Biopharmaceuticals (NAVB), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Statera Biopharma (STAB), and Evelo Biosciences (EVLO). These companies are all part of the "pharmaceutical products" industry.

Scopus BioPharma vs. Its Competitors

Scopus BioPharma (NASDAQ:SCPS) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Smart for Life'saverage media sentiment score.

Company Overall Sentiment
Scopus BioPharma Neutral
Smart for Life Neutral

28.4% of Smart for Life shares are held by institutional investors. 5.1% of Scopus BioPharma shares are held by insiders. Comparatively, 31.7% of Smart for Life shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Scopus BioPharmaN/A N/A N/A
Smart for Life N/A N/A N/A

Scopus BioPharma has higher earnings, but lower revenue than Smart for Life.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scopus BioPharmaN/AN/A-$11.61MN/AN/A
Smart for Life$11.11M0.00-$22.68MN/AN/A

Scopus BioPharma has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500. Comparatively, Smart for Life has a beta of 16.69, suggesting that its stock price is 1,569% more volatile than the S&P 500.

Summary

Smart for Life beats Scopus BioPharma on 4 of the 5 factors compared between the two stocks.

Get Scopus BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCPS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

SCPS vs. The Competition

MetricScopus BioPharmaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$13K$1.06B$6.12B$10.45B
Dividend YieldN/A4.84%5.73%4.77%
P/E RatioN/A1.2585.3327.36
Price / SalesN/A31.47601.99136.95
Price / CashN/A17.6437.4661.86
Price / BookN/A7.6612.566.81
Net Income-$11.61M-$7.71M$3.32B$276.80M
7 Day PerformanceN/A-0.76%0.59%0.42%
1 Month PerformanceN/A24.34%10.52%7.86%
1 Year PerformanceN/A-12.21%75.05%41.24%

Scopus BioPharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCPS
Scopus BioPharma
N/A$0.00
-70.0%
N/A+0.0%$13KN/A0.009
SMFL
Smart for Life
N/A$0.00
flat
N/A-92.3%$19K$11.11M0.00110Gap Down
VRPX
Virpax Pharmaceuticals
0.0784 of 5 stars
$0.01
-47.6%
N/A-99.9%$14KN/A0.007Gap Up
VAXX
Vaxxinity
N/A$0.00
flat
N/A-97.5%$13KN/A0.0090Gap Down
TRVN
Trevena
1.6737 of 5 stars
$0.01
flat
$5.00
+41,566.7%
-99.4%$12K$443K0.0040
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/AN/A$11KN/A0.0030Gap Up
NAVB
Navidea Biopharmaceuticals
N/AN/AN/AN/A$10K$8.13K0.0010High Trading Volume
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
STAB
Statera Biopharma
N/A$0.00
flat
N/A-50.0%$5KN/A0.0020High Trading Volume
EVLO
Evelo Biosciences
N/A$0.00
flat
N/A-33.3%$4KN/A0.00120News Coverage
Options Volume

Related Companies and Tools


This page (NASDAQ:SCPS) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners